Search
for
Sort by
Research 661–690 of 1000+
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Male hormonal contraception: looking back and moving forward
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- INTERFERONS IN DERMATOLOGY
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Teriflunomide in multiple sclerosis: an update
- Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change
- Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata
- Topical use of systemic drugs in dermatology: A comprehensive review
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- Finasteride improves motor, EEG, and cellular changes in rat brain in thioacetamide-induced hepatic encephalopathy
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Polycystic Ovarian Syndrome in Adolescents
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Characterization and causal investigations of an alopecia syndrome in Australian fur seals (<i>Arctocephalus pusillus doriferus</i>)
- Chemical Peels: Indications and Special Considerations for the Male Patient
- Dermatologic Reactions to Targeted Therapy
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome
- Management of hair loss diseases
- Alopecia Areata
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.